Posted by Michael Wonder on 29 Jan 2018
Statement by EMA Executive Director Guido Rasi in The Hague
29 January 2018 - EMA relocation project – press conference with Dutch authorities.
Good afternoon. I would like to thank the Dutch authorities for welcoming us here today and Minister Bruins for his opening remarks.
As you know, the UK announced its intention to withdraw from the EU on 29 March 2019. Therefore, last November the EU27 took the decision to relocate EMA from London to Amsterdam.
But who are we? And what does this move mean for the Agency and the Netherlands?
EMA was established 23 years ago and is responsible for the scientific evaluation of medicines for human and animal use in order to recommend them for an EU marketing authorisation. We also monitor the safety of all medicines marketed in the EU. Our role is key to ensuring that medicines on the EU market are safe, effective and of good quality, and that citizens across the EU can benefit from innovative and potentially life-saving medicinal products.
